JG
ARQT icon

Jain Global’s Arcutis Biotherapeutics ARQT Stock Holding History

Jain Global’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Buy
+73,141
New +$1.7M 0.01% 794
2026
Q1 		– Sell
-44,816
Closed -$1.3M – 1201
2025
Q4 		$1.3M Buy
+44,816
New +$1.15M 0.01% 669
2025
Q1 		– Sell
-32,601
Closed -$454K – 1064
2024
Q4 		$454K Buy
+32,601
New +$357K 0.01% 466

Other funds holding ARQT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jain Global's ARQT Position: Q2 2026 in Review

Jain Global opened a new position in Arcutis Biotherapeutics (ARQT) in Q2 2026: 73,141 shares worth $1.92M. The stake represents 0.01% of the portfolio and ranks #794 among its holdings. This is a return to the name: Jain Global previously reported a position in ARQT as recently as Q4 2025.

Jain Global first reported a position in ARQT in Q4 2024 and has held it in 3 quarters since. 273 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

  • Jain Global held 73,141 shares of Arcutis Biotherapeutics worth $1.92M as of Q2 2026.
  • Arcutis Biotherapeutics was a new Jain Global position in Q2 2026.
  • Arcutis Biotherapeutics made up 0.01% of Jain Global's portfolio in Q2 2026, its #794 holding.
  • Jain Global first reported a position in Arcutis Biotherapeutics in Q4 2024 and has held it in 3 quarters since.
  • 273 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.